pharmasvit портал из области здоровья, медицины, красоты, спорта и фармацевтики

Информационный бизнес-портал, целью которого является предоставление информации в области здоровья, медицины, красоты, спорта и фармацевтики

OVERVIEW

The domain pharmasvit.com presently has an average traffic ranking of zero (the lower the higher page views). We have analyzed twenty pages within the web site pharmasvit.com and found twenty-two websites associating themselves with pharmasvit.com. There is two contacts and addresses for pharmasvit.com to help you reach them. There is one social web platforms retained by pharmasvit.com. The domain pharmasvit.com has been online for one thousand two hundred and ninety-one weeks, twenty-eight days, nineteen hours, and seventeen minutes.
Pages Parsed
20
Links to this site
22
Contacts
2
Addresses
2
Social Links
1
Online Since
Oct 2000

PHARMASVIT.COM TRAFFIC

The domain pharmasvit.com is seeing varying levels of traffic for the whole of the year.
Traffic for pharmasvit.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for pharmasvit.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for pharmasvit.com

Date Range

All time
This Year
Last Year
Last Month

PHARMASVIT.COM HISTORY

The domain pharmasvit.com was first documented on October 13, 2000. It was last updated on the date of October 10, 2013. This web site will expire on the date of October 13, 2014. It is currently one thousand two hundred and ninety-one weeks, twenty-eight days, nineteen hours, and seventeen minutes young.
REGISTERED
October
2000
UPDATED
October
2013
EXPIRED
October
2014

SPAN

24
YEARS
8
MONTHS
29
DAYS

LINKS TO WEBSITE

WHAT DOES PHARMASVIT.COM LOOK LIKE?

Desktop Screenshot of pharmasvit.com Mobile Screenshot of pharmasvit.com Tablet Screenshot of pharmasvit.com

CONTACTS

DP KVM

--

7 Tsytadelna Street

Kiev, 01015

UA

Co.Ltd Topwot

--

Mashinostroitelnaya str/, 37

Kiev, 03067

UA

PHARMASVIT.COM SERVER

We revealed that a single page on pharmasvit.com took one thousand three hundred and seventy-five milliseconds to come up. Our parsers could not observe a SSL certificate, so therefore our parsers consider pharmasvit.com not secure.
Load time
1.375 sec
SSL
NOT SECURE
IP
62.149.0.54

NAME SERVERS

ns.dns.com.ua
ns2.dns.com.ua

SERVER SOFTWARE

We observed that pharmasvit.com is utilizing the nginx/1.10.2 server.

HTML TITLE

pharmasvit портал из области здоровья, медицины, красоты, спорта и фармацевтики

DESCRIPTION

Информационный бизнес-портал, целью которого является предоставление информации в области здоровья, медицины, красоты, спорта и фармацевтики

PARSED CONTENT

The domain has the following on the web page, "8482; 66885 страниц из мира медицины и фармацевтики, здоровья и красоты, спорта и образования." I observed that the web site also said " Знайте больше! Благотворительные организации, помощь." They also stated " Центры по проблеме ВИЧ СПИДа. Услуги для фармацевтики и медицины. Производители и поставщики медтехники и материалов. Маломощные больницы в регионах превратят в эффективные учреждения."

ANALYZE OTHER BUSINESSES

PharmaSwiss Srbija

Globalna procedura za sprečavanje korupcije. Rapidno protiv bola i povišene temperature. Rastvoreni Ibuprofen u sastavu mekih kapsula se brže resorbuje od Ibuprofena u konvencionalnim tabletama. Nove granulirane forme koje deluju brzo i.

PharmaSynapse

Thursday, January 21, 2010.

Фармасинтез

Узнайте все о приоритетах фармасинтез. Кадровый резерв со школьной скамьи. Представители компании Фармасинтез провели встречу со школьниками в городе Усолье-Сибирское. Выпускникам 9 и 11 классов рассказали о перспективах профессионального и карьерного роста на фармацевтическом предприятии.

PharmaSynth Pty Ltd - Australias most experienced biopharmaceutical contract manufacturing organisation

GMP manufacture of recombinant proteins and vaccines. Small molecule synthesis for human and veterinary use. Production of GMP material for pre-clinical studies and clinical trial material batches for Phase 1, 2 and 3 clinical studies.